PhRMA, Drugmakers Lose Bid to Halt Maryland Drug Pharmacy Law

Sept. 6, 2024, 2:32 PM UTC

A federal judge in Maryland rejected attempts from three drugmakers and a pharmaceutical trade group to block a Maryland law requiring manufacturers to distribute discounted drugs to an unlimited number of pharmacies.

Judge Matthew J. Maddox of the US District Court for the District of Maryland on Thursday denied motions for preliminary injunction in lawsuits filed by Novartis Pharmaceuticals Corp., AbbVie Inc., AstraZeneca PLC, and the Pharmaceutical Research and Manufacturers of America.

The drugmakers and the industry group sued the state over its law (H.B. 1056) that requires manufacturers in the 340B Drug Pricing Program ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.